BICO Group Overview
Pro stress-test →BICO Group is a Swedish bioconvergence company that designs and supplies technologies and services to enhance biology research, focusing on commercializing technologies for life science research and bioprinting. With 32,000+ instruments installed in over 65 countries, BICO products and solutions are found in more than 3,500 laboratories, including the world's top 20 pharmaceutical companies.
Strategic Profile
Pro stress-test →BICO transitioned to a bioconvergence company in 2020, expanding its focus from bioprinting to broader life sciences technology and industrial solutions. Operating through three business areas – Bioprinting, Biosciences and Bioautomation – the BICO Group strives towards the long-term ambition of enabling the reduction of the world's organ shortage and speeding up drug development. BICO is a prominent player in the global 3D bioprinting market, boasting a diversified portfolio of products for 3D cell cultures for high-throughput drug screening and printing of human tissues and organs.
Competitive Landscape
Pro stress-test →3D Systems holds strong position in 3D bioprinting market with strong product portfolio of bioprinters, bioinks and software, emphasizing collaboration with governments and non-profit organizations. Other competitors include Merck KGaA, Organovo Holdings, Collplant Biotechnologies, regenHU, Aspect Biosystems, and Rokit Healthcare. BICO differentiates through diversified bioconvergence platform combining robotics, AI, genomics and bioprinting.
Industry Context
BICO Group operates in Biotech/Life Sciences Infrastructure - 3D Bioprinting, Lab Automation & Cell Culture.
Key facts
Founded: 2016 · Headquarters: Gothenburg, Sweden · Employees: N/A · Revenue: N/A · Market cap: N/A